Please login to the form below

Not currently logged in

Two sides of Sales Force Effectiveness

The medical sales role is changing, healthcare professionals are now driving the relationships and pharma needs to respond with a more service-centric model.

We look at the role that sales force effectiveness plays within this evolving environment and focus on two key aspects, coaching and compensation.

This webinar will discuss and examine these two dimensions and will share experiences of driving best practice.

Speaker Biographies:

Jason Bryant
Jason Bryant 
is responsible for developing Data Intelligence's client base in commercial terms both at home and abroad. Jason's background includes analytics consulting, most recently at Cognizant Europe (marketRx), business development and client-side business intelligence, data warehousing and CRM management.

Prior to joining Cognizant Jason was responsible for building the pharmaceutical business for Binley's, coming to this from a range of BI roles at Sanofi-Aventis.


Christian AgerChristian Ager has worked in the pharmaceutical industry since 2005, with deep involvement in SFE projects for a number of companies of varying sizes. He has worked both client-side and agency-side with experience at Kantar Health (formerly TNS Healthcare) and, more recently, at Bristol-Myers Squibb.

Christian's focus for Data Intelligence is on analytics, with a specialism in quota-setting and incentive compensation. He is also the lead consultant for the PharmaPRECISION (Analytics Consulting) suite and he leads report and dashboard design for clients’ reporting platforms. Christian’s emphasis for 2014 at Data Intelligence is on helping clients to optimise their sales incentive management and target-setting processes.

COVID-19 Updates and Daily News

Featured jobs


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...